Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy
The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with an unknown etiology and currently few effective therapies. Immune system alterations have being demonstrated in ASD, both in humans and via animal models; immune imbalance thus arises as a possible pathway for drug intervention. In this review, the studies were classified into 2 major groups: (1) clinical research whose authors classify therapies with primary anti-inflammatory and immunomodulatory actions, making use of: sulforaphane, celecoxib, lenalidomide, pentoxifylline, spironolactone, flavonoid luteolin, corticosteroids, oral immunoglobulin, intravenous immunoglobulin, cell therapy, dialyzable lymphocyte extracts, minocycline, and pioglitazone; and (2) other ASD therapies already used or currently under study whose initial characteristics were neither anti-inflammatory nor immunomodulatory initially, but displayed a capacity for immunomodulation throughout the treatment: risperidone, vitamin D, omega-3, Ginkgo biloba, L-carnosine, N-acetylcysteine, and microbiome restoration. These studies used various data acquisition methodologies. Questions arose such the need for randomized and placebo-controlled studies with greater numbers of participants as well as the use of biomarkers to refine the treatment of autistic subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, studies in human and animal models indicate immunological dysfunction in ASD (61), while recent research highlights the co-ocurrence of mast cell dysregulation in EDS (62, 63) suggesting problems in the immune system.”
From Autism, joint hypermobility-related disorders and pain (2018) · cites this paper as [61]
Citations
Cites
1 retracted
Saad, K., Abdel‐Rahman, A. A., Elserogy, Y. M., Al‐Atram, A. A., El‐Houfey, A. A., Othman, H. A. K., Bjørklund, G., Jia, F., Urbina, M. A., Abo‐Elela, M. G. M., et al. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12652 · Cited by 99
RetractedMiddleton, E., Kandaswami, C., & Theoharides, T. C. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01472-8 · Cited by 4,882
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391
Costs of Autism Spectrum Disorders in the United Kingdom and the United States
Buescher, A. V. S., Cidav, Z., Knapp, M., & Mandell, D. S. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.210 · Cited by 1,296
The epidemiology and global burden of autism spectrum disorders
Baxter, A. J., Brugha, T. S., Erskine, H. E., Scheurer, R. W., Vos, T., & Scott, J. G. (2015) · Psychological Medicine · doi:10.1017/s003329171400172x · Cited by 1,224
Distribution and biological activities of the flavonoid luteolin
Lopez-Lazaro, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001712 · Cited by 1,106
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940
Molecular basis for chemoprevention by sulforaphane: a comprehensive review
Juge, N., Mithen, R. F., & Traka, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6484-5 · Cited by 693
Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500701 · Cited by 614
Cited by
Brain-body interactions underlying the association of loneliness with mental and physical health
Quadt, L., Esposito, G., Critchley, H. D., & Garfinkel, S. N. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.015 · Cited by 137
Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy
Zhuang, H., Liang, Z., Ma, G., Qureshi, A., Ran, X., Feng, C., Liu, X., Yan, X., & Shen, L. (2024) · MedComm · doi:10.1002/mco2.497 · Cited by 136
The role of natural products in revealing NRF2 function
Zhang, D. D., & Chapman, E. (2020) · Natural Product Reports · doi:10.1039/c9np00061e · Cited by 124
Trzmiel, T., Purandare, B., Michalak, M., Zasadzka, E., & Pawlaczyk, M. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.11.004 · Cited by 96
Chang, J. P., & Su, K. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.4.469 · Cited by 82
Autism, joint hypermobility-related disorders and pain
Baeza-Velasco, C., Cohen, D., Hamonet, C., Vlamynck, E., Diaz, L., Cravero, C., Cappe, E., & Guinchat, V. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00656 · Cited by 78
Carpita, B., Marazziti, D., Palego, L., Giannaccini, G., Betti, L., & Dell’Osso, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190328151539 · Cited by 60
Singh, R., Kisku, A., Kungumaraj, H. J., Nagaraj, V., Pal, A., Kumar, S., & Sulakhiya, K. (2023) · Biomedicines · doi:10.3390/biomedicines11010115 · Cited by 52
Emerging drugs for the treatment of irritability associated with autism spectrum disorder
Shamabadi, A., Karimi, H., Bahri, R. A., Motavaselian, M., & Akhondzadeh, S. (2024) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2024.2313650 · Cited by 50
Dietary Approaches to the Management of Autism Spectrum Disorders
Hartman, R. E., & Patel, D. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_19 · Cited by 49
Leo, E. D., Elmonem, M. A., Berlingerio, S. P., Berquez, M., Festa, B. P., Raso, R., Bellomo, F., Starborg, T., Janssen, M. J., Abbaszadeh, Z., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019090956 · Cited by 48
Mazahery, H., Conlon, C. A., Beck, K. L., Mugridge, O., Kruger, M. C., Stonehouse, W., Camargo, C. A., Meyer, B. J., Tsang, B., & von Hurst, P. R. (2020) · Nutrients · doi:10.3390/nu12030661 · Cited by 45
The immune system and autism spectrum disorder: association and therapeutic challenges
Heidari, A., Abadi, Y. R., & Rezaei, N. (2022) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2021-023 · Cited by 44
Sukiennik, R., Marchezan, J., & Scornavacca, F. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.598073 · Cited by 42
Self-citationCurrent Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases
Soares, M. B. P., Gonçalves, R. G. D. J., Vasques, J. F., da Silva‐Junior, A. J., Gubert, F., Santos, G. C., de Santana, T. A., Sampaio, G. L. D. A., Silva, D. N., Dominici, M., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.883378 · Cited by 35
Microglia as possible therapeutic targets for autism spectrum disorders
Andoh, M., Ikegaya, Y., & Koyama, R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.012 · Cited by 35
Autism - A Comprehensive Array of Prominent Signs and Symptoms
Nadeem, M. S., Murtaza, B. N., Al-Ghamdi, M. A., Ali, A., Zamzami, M. A., Khan, J. A., Ahmad, A., Rehman, M. U., & Kazmi, I. A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210120095829 · Cited by 33
Sharp, H. E. C., Critchley, H. D., & Eccles, J. A. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i10.805 · Cited by 32
Autoimmune Encephalitis and Autism Spectrum Disorder
Whiteley, P., Marlow, B. P., Kapoor, R. R., Blagojevic-Stokic, N., & Sala, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.775017 · Cited by 30
Jęśko, H. M., Cieślik, M., Gromadzka, G., & Adamczyk, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104853 · Cited by 30
Altered Caecal Neuroimmune Interactions in the Neuroligin-3R451C Mouse Model of Autism
Sharna, S. S., Balasuriya, G. K., Hosie, S., Nithianantharajah, J., Franks, A. E., & Hill‐Yardin, E. L. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00085 · Cited by 29
A retrospective analysis of memantine use in a pediatric neurology clinic
Bouhadoun, S., Poulin, C., Berrahmoune, S., & Myers, K. A. (2021) · Brain and Development · doi:10.1016/j.braindev.2021.05.012 · Cited by 25
Dopamine–mediated immunomodulation affects choroid plexus function
Castellani, G., Contarini, G., Mereu, M., Albanesi, E., Devroye, C., D’Amore, C., Ferretti, V., Martin, S. D., & Papaleo, F. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.006 · Cited by 25
Wang, W., & Fu, P. (2023) · Microorganisms · doi:10.3390/microorganisms11020291 · Cited by 24
Pandina, G., Ring, R. H., Bangerter, A., & Ness, S. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.08.003 · Cited by 23
Angrand, L., Masson, J.-D., Rubio‐Casillas, A., Nosten‐Bertrand, M., & Crépeaux, G. (2022) · Toxics · doi:10.3390/toxics10090518 · Cited by 22
The Physiology of Cognition in Autism Spectrum Disorder: Current and Future Challenges
Al-Mazidi, S. H. (2023) · Cureus · doi:10.7759/cureus.46581 · Cited by 22
Available Treatments for Autism Spectrum Disorder: From Old Strategies to New Options
Dell’Osso, L., Bonelli, C., Giovannoni, F., Poli, F., Anastasio, L., Cerofolini, G., Nardi, B., Cremone, I. M., Pini, S., & Carpita, B. (2025) · Pharmaceuticals · doi:10.3390/ph18030324 · Cited by 20
Napoli, E., Flores, A., Mansuri, Y., Hagerman, R. J., & Giulivi, C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105427 · Cited by 20
Potential natural products for the management of autism spectrum disorder
Sachdeva, P., Mehdi, I., Kaith, R., Ahmad, F., & Anwar, M. S. (2022) · Ibrain · doi:10.1002/ibra.12050 · Cited by 20
Food, nutrition, and autism: from soil to fork
Maitin‐Shepard, M., O’Tierney-Ginn, P., Kraneveld, A. D., Lyall, K., Fallin, M. D., Arora, M., Fasano, A., Mueller, N. T., Wang, X., Caulfield, L. E., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.04.020 · Cited by 19
Cell therapy approaches to autism: a review of clinical trial data
Price, J. (2020) · Molecular Autism · doi:10.1186/s13229-020-00348-z · Cited by 19
Unnisa, A., Greig, N. H., & Kamal, M. A. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221221142743 · Cited by 18
Targeted Biomedical Treatment for Autism Spectrum Disorders
Pacheva, I. H., & Ivanov, I. S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191205091312 · Cited by 18
Pandina, G., Ring, R. H., Bangerter, A., & Ness, S. L. (2020) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.12.004 · Cited by 18
Erdoğan, M. A., Nesil, P., Altuntas, I., Şirin, C., Uyanıkgil, Y., & Erbaş, O. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.013 · Cited by 15
Cell Therapies for Autism Spectrum Disorder Based on New Pathophysiology: A Review
Nabetani, M., Mukai, T., & Taguchi, A. (2023) · Cell Transplantation · doi:10.1177/09636897231163217 · Cited by 13
Natural Products and Their Therapeutic Effect on Autism Spectrum Disorder
Deb, S., Phukan, B. C., Dutta, A., Paul, R. K., Bhattacharya, P., Manivasagam, T., Thenmozhi, A. J., Chidambaram, S. B., Essa, M. M., & Borah, A. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_22 · Cited by 12
Farrag, E. A. E., Askar, M. H., Abdallah, Z., Mahmoud, S. M., Abdulhai, E. A., Abdel-Razik, E. A., Nashar, E. M. E., Alasiri, F. M., Alqahtani, A. N. S., Eldesoqui, M. B., et al. (2024) · Behavioral and Brain Functions · doi:10.1186/s12993-024-00250-1 · Cited by 11
Chemical Modulators for Targeting Autism Spectrum Disorders: From Bench to Clinic
Lim, S., & Lee, S. (2022) · Molecules · doi:10.3390/molecules27165088 · Cited by 11
Yao, Y., Uddin, M. N., MANLEY, K. M., & Lawrence, D. A. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3684 · Cited by 10
Kim, K., Sohn, J. H., Cho, S. J., Seo, H. Y., Kim, S., & Hong, Y. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058286 · Cited by 10
Combination of Steroid and Flavonoid for the Treatment of Regressive Autism
Ekici, B. (2020) · Journal of Neurosciences in Rural Practice · doi:10.1055/s-0040-1701367 · Cited by 7
Мальцев, Д. В. (2021) · Психиатрия психотерапия и клиническая психология · doi:10.34883/pi.2021.12.3.010 · Cited by 7
Saleem, H., Anwar, S., Alafnan, A. D., & Ahemad, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822923-1.00022-4 · Cited by 7
Gaspar, J. M., Ferreira, J. P., Carvalho, H. M., & Toscano, C. V. A. (2024) · Brain Sciences · doi:10.3390/brainsci14111052 · Cited by 6
Saliva FTIR Spectra and Machine Learning for Autism Spectrum Disorder Diagnosis—Preliminary Study
Pinto, M. M. V., Arisawa, E. Â. L. S., Raniero, L. J., & Bhattacharjee, T. (2025) · IEEE photonics journal · doi:10.1109/jphot.2025.3561020 · Cited by 5
Nutrition Therapy Approaches in Children with Autism Spectrum Disorder
AKHALİL, M., Çiftçi, S., & Batu, Z. (2023) · Farabi Tıp Dergisi · doi:10.59518/farabimedj.1237543 · Cited by 5
Gonçalves, B. P., Silva, E. D. S., Luçardo, J. D. C., Fernandes, M. P., Grokoski, K. C., Vaz, J. D. S., & Valle, S. C. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04472 · Cited by 5
Advances in Pharmacological Treatments for Cystinosis: Cysteamine and Its Alternatives
Carneiro, A., & Jones, D. H. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00633 · Cited by 4
Overactivation of Microglia as a Shared Pathophysiology in Different Neuropsychiatric Disorders
Eltokhi, A. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_11 · Cited by 4
Erdoğan, M. A., Tunç, K. C., DAŞTAN, A. İ., Tomruk, C., Uyanıkgil, Y., & Erbaş, O. (2024) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10394 · Cited by 4
Мальцев, Д. В. (2021) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.3.2021.03 · Cited by 4
Greydanus, D. E., Patel, D. R., & Rowland, D. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00085-2 · Cited by 4
Murad, N. A. A. (2022) · Asian Journal of Medicine and Biomedicine · doi:10.37231/ajmb.2022.6.2.262 · Cited by 3
Ciolino, A. E., Ferreira, M. L., & Loyacono, N. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14101031 · Cited by 3
Pinto, M. M. V., Arisawa, E. Â. L. S., Lopes‐Martins, R. Á. B., & Raniero, L. J. (2021) · Research Society and Development · doi:10.33448/rsd-v10i10.18924 · Cited by 3
Мальцев, Д. В. (2021) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.17.5.2021.238518 · Cited by 3
Future perspectives on cell therapy for autism spectrum disorder
Nabetani, M., & Mukai, T. (2021) · Biocell · doi:10.32604/biocell.2022.018218 · Cited by 3
Мальцев, Д. В. (2022) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.17.8.2021.250818 · Cited by 3
Immunotherapy: An Approach to Treat Alzheimer’s Disease and Autism Spectrum Disorder
Maarfi, F., Hasan, Z., Khanam, A., Husain, A., Khan, M. H., & Khan, M. Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-4558-7_11 · Cited by 3
Nosratiyan, N., Ghasemi‐Kasman, M., Pourghasem, M., Feizi, F., & Sadeghi, F. (2025) · Brain Sciences · doi:10.3390/brainsci15080798 · Cited by 2
Vitamin D and Autism Spectrum Disorder
Vegelin, M., Teodorowicz, G., & Savelkoul, H. F. J. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96928 · Cited by 2
Effect of gender on salivary immunoglobulin and complements in autism children
Abd, S. T., Abdullah, W. L., Saleem, M. A., Mutlak, S. S., & Hasson, Z. T. (2023) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_365_23 · Cited by 1
Therapeutic Effect of LEV in a Propionic Acid‐Induced Autism Model via AMPK/SIRT1 Pathway
MECİT, T., Altuntaş, İ., Erdoğan, M. A., Uyanıkgil, Y., & Erbaş, O. (2025) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.70055 · Cited by 1
Complementary and Alternative Treatments for Autism Spectrum Disorder: A Comprehensive Review
Demir, M. H. B. (2026) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1616996 · Cited by 1
التأثير العلاجي لبعض النباتات على الفئران المصابة بالتوحد
أحمد, ع., الطحان, ن., الشريف, س., & السعدنى, م. (2018) · Mağallaẗ Al-Iqtiṣād Al-Manzilī - Ǧāmiʿaẗ Al-Munūfiyyaẗ · doi:10.21608/mkas.2018.165087 · Cited by 1
Immunological biomarkers in autism: a review
Chowdhury, M. A. (2020) · BRAC University Institutional Repository (BRAC University)
ІМУНОГЕНЕТИЧНІ АСПЕКТИ ПАТОГЕНЕЗУ ХВОРОБИ У ДІТЕЙ ІЗ РОЗЛАДАМИ СПЕКТРА АУТИЗМУ
Мальцев, Д. В., & Kolіadenko, N. V. (2023) · Men’s Health Gender and Psychosomatic Medicine · doi:10.37321/ujmh.2022.1-2-05
Immune-Dependent Mechanisms of Encephalopathy in Children with Autism Spectrum Disorders
Мальцев, Д. В., & Kolіadenko, N. V. (2023) · Педиатрия Восточная Европа · doi:10.34883/pi.2022.10.4.010
The Immune System and the Plural Autisms: A Narrative Review
Whiteley, P., Carr, K., Shattock, P., Hooper, M., Stott, C., Hardy, K., Marlow, B. P., Mukherjee, C. R., & Whiteley, A. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16070379
Immunotherapy in Autism Spectrum Disorder: a critical view from Clinical Immunology experts
Goudouris, E. S., Aranda, C. S., Antunes, A. A., Prado, A. I., Falcão, A. C. A. M., Condino‐Neto, A., Prando, C., Kokron, C. M., Tavares, F. S., Mariz, F. P., et al. (2025) · Arquivos de Asmas Alergia e Imunologia · doi:10.4322/2526-5393.20250039
Metadata
- Authors
- Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S.
- Affiliations
- Universidade Federal do Rio Grande do Sul (BR)
- Venue
- Neuroimmunomodulation
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 25
- Issue
- 5-6
- Pages
- 300-319
- ISSN
- 1021-7401 (ISSN-L)
- 1423-0216
- OpenAlex
- W2892087768
- Cited by
- 70
- References
- 236
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 4 · 2018: 3
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- NeuroImmunoModulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, immune dysfunction, immunomodulatory therapy, anti-inflammatory therapy, sulforaphane, celecoxib, lenalidomide, pentoxifylline, spironolactone, luteolin, corticosteroids, intravenous immunoglobulin, oral immunoglobulin, cell therapy, minocycline, pioglitazone, risperidone, vitamin D, omega-3 fatty acids, Ginkgo biloba, L-carnosine, N-acetylcysteine, microbiota restoration, biomarkers
- MeSH terms
- Autism Spectrum Disorder, Animals, Humans, Immunotherapy, Neuroimmunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.